Mia's Feed
Medical News & Research

Global Decline in Chronic Disease Mortality Shows Signs of Slowing Progress

Global Decline in Chronic Disease Mortality Shows Signs of Slowing Progress

Share this article

A new study reveals that while deaths from chronic diseases are declining worldwide, the rate of improvement is slowing, emphasizing the need for stronger global health efforts. Read more about the latest findings and implications for future strategies.

1 min read

Recent research published in The Lancet indicates that while mortality rates from chronic diseases such as cancer, cardiovascular conditions, diabetes, and neurological disorders have decreased in nearly 80% of countries worldwide over the past decade, the pace of this decline is gradually slowing down. The comprehensive analysis, led by experts from Imperial College London, highlights that in the period from 2010 to 2019, many nations experienced a deceleration in the reduction of death rates related to non-communicable diseases (NCDs). Notably, high-income countries—including those in Europe, North America, Australasia, and the Pacific—showed a significant slowdown, with the United States marked as one of the poorer performers among developed nations. These findings come ahead of the Fourth High-level Meeting of the UN General Assembly, underscoring an urgent need for enhanced investments and strategic approaches to address chronic diseases more effectively. Despite the global decrease, the trend signals a critical juncture requiring intensified efforts to sustain and accelerate progress in reducing preventable mortality caused by non-communicable diseases.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Experts Warn That Focusing Solely on Weight Loss May Harm Overall Health in Obesity Management

Emerging medical research suggests that prioritizing weight loss alone in obesity treatment may be ineffective and could harm overall health. Experts advocate for a holistic, patient-centered approach that emphasizes overall well-being beyond mere weight reduction.

Breakthrough Study Identifies Cellular Source of Inflammation in Spondyloarthritis

A groundbreaking study identifies CD4+ tissue-resident TRM17 cells as the main source of IL-17 driving inflammation in spondyloarthritis, opening new possibilities for targeted therapies to control joint inflammation more effectively.

Artificial Sweetener Sucralose May Reduce Effectiveness of Cancer Immunotherapy

Emerging research indicates that the artificial sweetener sucralose may reduce the effectiveness of cancer immunotherapy by altering gut microbiota and immune cell function. Learn what this means for cancer patients and their dietary choices.

NIH Sets Limit on Publishing Fees for Publicly Funded Research by 2026

NIH to implement a cap on publishing fees for research funded by the government starting in 2026, aiming to reduce costs and improve access to scientific findings.